$730 Million is the total value of SILVERBACK ASSET MANAGEMENT LLC's 92 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPY | New | SPDR S&P 500 ETF TRtr unit | $42,748,000 | – | 100,000 | +100.0% | 5.86% | – |
| New | INFINERA CORPnote 3.750% 8/0 | $19,892,956 | – | 21,535,000 | +100.0% | 2.73% | – | |
| New | INFINERA CORPnote 2.500% 3/0 | $15,983,913 | – | 18,000,000 | +100.0% | 2.19% | – | |
| New | MACOM TECH SOLUTIONS HLDGS Inote 0.250% 3/1 | $13,821,813 | – | 12,151,000 | +100.0% | 1.90% | – | |
| New | POST HLDGS INCnote 2.500% 8/1 | $8,481,997 | – | 8,530,000 | +100.0% | 1.16% | – | |
| New | TRAVERE THERAPEUTICS INCnote 2.250% 3/0 | $8,093,188 | – | 12,500,000 | +100.0% | 1.11% | – | |
| New | Cryoport Incnote 0.750% 12/01/26 | $7,433,598 | – | 9,311,000 | +100.0% | 1.02% | – | |
| New | 8X8 INC NEWnote 4.000% 2/0 | $5,379,750 | – | 7,500,000 | +100.0% | 0.74% | – | |
| New | REVANCE THERAPEUTICS INCnote 1.750% 2/1 | $4,034,417 | – | 5,000,000 | +100.0% | 0.55% | – | |
| New | BRIDGEBIO PHARMA INCnote 2.250% 2/0 | $3,750,375 | – | 5,000,000 | +100.0% | 0.51% | – | |
| New | CRACKER BARREL OLD CTRY STORnote 0.625% 6/1 | $3,597,143 | – | 4,347,000 | +100.0% | 0.49% | – | |
| New | TPI Composites Incnote 5.250% 03/15/28 | $2,456,161 | – | 5,000,000 | +100.0% | 0.34% | – | |
| New | OMEROS CORPnote 5.250% 2/1 | $1,613,889 | – | 2,663,000 | +100.0% | 0.22% | – | |
| INFN | New | INFINERA CORP | $1,045,000 | – | 250,000 | +100.0% | 0.14% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $357,600 | – | 40,000 | +100.0% | 0.05% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $290,000 | – | 100,000 | +100.0% | 0.04% | – |
| DNMR | New | DANIMER SCIENTIFIC INC | $103,500 | – | 50,000 | +100.0% | 0.01% | – |
| KAII | New | QUADRO ACQUISITION ONE CORP | $18 | – | 366 | +100.0% | 0.00% | – |
| New | ZAPP ELEC VEHS GROUP LTD | $200 | – | 7,961 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAGNACHIP SEMICONDUCTOR CORP | 25 | Q3 2023 | 1.4% |
| SREV Equity | 24 | Q1 2022 | 2.0% |
| Sanofi Aventis CVR-WI | 21 | Q3 2019 | 0.3% |
| INFINERA CORPORATION | 19 | Q1 2023 | 6.1% |
| SPY 07/31/15 P190 | 17 | Q2 2023 | 31.6% |
| VECTOR GROUP LTD | 17 | Q2 2018 | 6.5% |
| AKTS Equity | 17 | Q3 2023 | 2.1% |
| DISH NETWORK CORPORATION | 16 | Q3 2023 | 3.5% |
| FLEXION THERAPEUTICS INC | 14 | Q3 2021 | 4.2% |
| PATRICK INDS INC | 14 | Q3 2022 | 2.7% |
View SILVERBACK ASSET MANAGEMENT LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| James River Coal CO | February 12, 2014 | 3,444,400 | 8.7% |
| TRICO MARINE SERVICES INCSold out | February 07, 2011 | 0 | 0.0% |
| ORBITAL SCIENCES CORP /DE/Sold out | March 12, 2009 | 0 | 0.0% |
| DOR BIOPHARMA INCSold out | February 14, 2007 | 0 | 0.0% |
| OXIS INTERNATIONAL INCSold out | February 14, 2007 | 0 | 0.0% |
| YM BIOSCIENCES INC | February 14, 2006 | 870,100 | 2.3% |
View SILVERBACK ASSET MANAGEMENT LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-11 |
| 4 | 2024-03-15 |
| SC 13D/A | 2024-03-15 |
| SC 13D/A | 2024-02-15 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2024-02-02 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-10-06 |
| SC 13D/A | 2023-09-14 |
| 13F-HR/A | 2023-08-17 |
View SILVERBACK ASSET MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.